Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022
Abstract This article summarizes the drug therapy progress of advanced hepatocellular carcinoma, biliary tract cancer, and pancreatic cancer in 2022, including chemotherapy, molecular targeted therapy, and immunotherapy, to provide reference information for current clinical treatment and future clin...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Series: | Cancer Innovation |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cai2.60 |
| _version_ | 1828001467405959168 |
|---|---|
| author | Le Zhang Rui Liu Ting Deng Yi Ba |
| author_facet | Le Zhang Rui Liu Ting Deng Yi Ba |
| author_sort | Le Zhang |
| collection | DOAJ |
| description | Abstract This article summarizes the drug therapy progress of advanced hepatocellular carcinoma, biliary tract cancer, and pancreatic cancer in 2022, including chemotherapy, molecular targeted therapy, and immunotherapy, to provide reference information for current clinical treatment and future clinical research, and to better improve prognosis and quality of life in patients with hepatobiliary and pancreatic cancer. |
| first_indexed | 2024-04-10T06:28:49Z |
| format | Article |
| id | doaj.art-ba3100631aec49848050cac874859974 |
| institution | Directory Open Access Journal |
| issn | 2770-9183 |
| language | English |
| last_indexed | 2024-04-10T06:28:49Z |
| publishDate | 2023-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Innovation |
| spelling | doaj.art-ba3100631aec49848050cac8748599742023-03-01T13:14:09ZengWileyCancer Innovation2770-91832023-02-0121365110.1002/cai2.60Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022Le Zhang0Rui Liu1Ting Deng2Yi Ba3Department of Gastrointestinal Medical Oncology National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaDepartment of Gastrointestinal Medical Oncology National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaDepartment of Gastrointestinal Medical Oncology National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaDepartment of Gastrointestinal Medical Oncology National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital Tianjin ChinaAbstract This article summarizes the drug therapy progress of advanced hepatocellular carcinoma, biliary tract cancer, and pancreatic cancer in 2022, including chemotherapy, molecular targeted therapy, and immunotherapy, to provide reference information for current clinical treatment and future clinical research, and to better improve prognosis and quality of life in patients with hepatobiliary and pancreatic cancer.https://doi.org/10.1002/cai2.60hepatocellular carcinomabiliary tract cancercholangiocarcinomapancreatic cancerchemotherapytargeted therapy |
| spellingShingle | Le Zhang Rui Liu Ting Deng Yi Ba Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022 Cancer Innovation hepatocellular carcinoma biliary tract cancer cholangiocarcinoma pancreatic cancer chemotherapy targeted therapy |
| title | Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022 |
| title_full | Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022 |
| title_fullStr | Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022 |
| title_full_unstemmed | Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022 |
| title_short | Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022 |
| title_sort | advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022 |
| topic | hepatocellular carcinoma biliary tract cancer cholangiocarcinoma pancreatic cancer chemotherapy targeted therapy |
| url | https://doi.org/10.1002/cai2.60 |
| work_keys_str_mv | AT lezhang advancesinmedicaltreatmentofadvancedhepatobiliaryandpancreaticcancerin2022 AT ruiliu advancesinmedicaltreatmentofadvancedhepatobiliaryandpancreaticcancerin2022 AT tingdeng advancesinmedicaltreatmentofadvancedhepatobiliaryandpancreaticcancerin2022 AT yiba advancesinmedicaltreatmentofadvancedhepatobiliaryandpancreaticcancerin2022 |